BRAF/MEK inhibitor-induced tumor lysis syndrome in a patient with malignant melanoma

被引：0
|
作者：
Maeda, Shintaro [1 ]
Imazaki, Katsuya [1 ]
Shimizu, Kyoko [1 ]
Oishi, Kyosuke [1 ]
Hamaguchi, Yasuhito [1 ]
Matsushita, Takashi [1 ]
机构：
[1] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Med, Dept Mol Pathol Skin, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan
来源：
JOURNAL OF DERMATOLOGY | 2025年 / 52卷 / 03期
关键词：
D O I：
10.1111/1346-8138.17507
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：e242 / e243
页数：2
相关论文
共 50 条
  • [21] Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma
    Welsh, Sarah J.
    Corrie, Pippa G.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2015, 7 (02) : 122 - 136
  • [22] Acute demyelinating Polyradiculoneuropathy with CSF Pleocytosis under Therapy with BRAF/MEK Inhibitor in advanced malignant Melanoma
    Hecker, C.
    Madzar, D.
    Schultz, E.
    Debus, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 55 - 56
  • [23] Diffuse melanosis after chemotherapy-induced tumor lysis syndrome in a patient with metastatic melanoma
    Busam, KJ
    Wolchok, J
    Jungbluth, AA
    Chapman, P
    JOURNAL OF CUTANEOUS PATHOLOGY, 2004, 31 (03) : 274 - 280
  • [24] Patient with stage IV melanoma with BRAF mutation - immunotherapy or BRAF and MEK inhibitors?
    Cybulska-Stopa, Bozena
    Ziobro, Marek
    ONCOLOGY IN CLINICAL PRACTICE, 2018, 14 (02): : 100 - 103
  • [25] DRESS syndrome in a patient with metastatic malignant melanoma induced by targeted therapy with the BRAF inhibitors vemurafenib and dabrafenib
    Pickert, J. E.
    Mobs, C.
    Schulze-Dasbeck, M.
    Logenthiran, L.
    Gschnell, M.
    Muhlenbein, S.
    Pfutzner, W.
    Bender, A.
    EXPERIMENTAL DERMATOLOGY, 2019, 28 (03) : E11 - E11
  • [26] BRAF inhibitor-induced panniculitis in patients treated for stage IV metastatic melanoma: a case series
    David J. Bartlett
    Andrew J. Erie
    Francis I. Baffour
    Stephen M. Broski
    Katrina N. Glazebrook
    Skeletal Radiology, 2021, 50 : 1257 - 1262
  • [27] HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E
    Cheng, Lingxiao
    Jin, Yuchen
    Liu, Min
    Ruan, Maomei
    Chen, Libo
    ONCOTARGET, 2017, 8 (12) : 19843 - 19854
  • [28] BRAF inhibitor-induced panniculitis in patients treated for stage IV metastatic melanoma: a case series
    Bartlett, David J.
    Erie, Andrew J.
    Baffour, Francis I.
    Broski, Stephen M.
    Glazebrook, Katrina N.
    SKELETAL RADIOLOGY, 2021, 50 (06) : 1257 - 1262
  • [29] Tumor lysis syndrome and metastatic melanoma
    Marshall W. Meeks
    Muhammad B. Hammami
    Katherine J. Robbins
    Kevin L. Cheng
    Jack M. Lionberger
    Medical Oncology, 2016, 33
  • [30] Tumor lysis syndrome and metastatic melanoma
    Meeks, Marshall W.
    Hammami, Muhammad B.
    Robbins, Katherine J.
    Cheng, Kevin L.
    Lionberger, Jack M.
    MEDICAL ONCOLOGY, 2016, 33 (12)
12345